In view of the plans made by national health authorities in every country across the world for the widespread vaccination of individuals against the SARS-CoV-2 virus, the Thalassaemia International Federation herein presents the latest information concerning the to-date authorized vaccinations, as well as the Federation’s position about the vaccination of patients with haemoglobin disorders against SARS-CoV-2.
Οκτ 13, 2020
The Emirates Thalassaemia Society launches the 12th edition of the ”What is Thalassaemia?”competition
Δεκ 19, 2019
Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System
2 εβδομάδες ago
TIF and Hemanext® Inc. Announce New Strategic AllianceΙουν 15, 2020